Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
Prospective, multicenter, open label, phase III randomized clinical trial in previously untreated Follicular Lymphoma in early stage. Patients will be randomized to receive Radiotherapy or Radiotherapy plus Obinutuzumab.
Epistemonikos ID: 05d08f46d792ca466ea3d1787929420f8ee46a74
First added on: May 15, 2024